Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 22, 2025Blood Cancer DiscoveryOpen Access

B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements

View Full Paper
Ask AI
Bookmark
Share

Authors

GVGabriele VaranoIFOMSLSilvia LonardiAzienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaPSPaola SindacoIFOM

Discussion

Loading...

Member takes

Overview

Randomized trial reveals B-cell receptor silencing impacts high-grade B-cell lymphomas, indicating treatment resistance.

Key Points

  • This research aims to explore the mechanisms of B-cell receptor silencing in high-grade B-cell lymphomas with MYC and BCL2 rearrangements.
  • Analyzed immunoglobulin heavy chain expression and rearrangements in B-cell lymphomas
  • Investigated the role of RAG1/2 in IG light chain editing
  • Assessed sensitivity to the CD79B-targeting drug polatuzumab vedotin in HGBCL models.
  • IGH-silenced tumors demonstrate distinct immune profiles and MYC expression compared to IGH+ tumors.
  • IGHUND lymphomas maintain productive IGHV rearrangements and require IGH for optimal growth.
  • BCR silencing in these lymphomas leads to reduced sensitivity to polatuzumab vedotin.

Cite This Study

Varano et al. (2025) studied this question.

synapsesocial.com/papers/6a64c094b8d89366c3b14f67https://doi.org/10.1158/2643-3230.bcd-25-0099
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1B cell receptor silencing reveals the origin of high-grade B cell lymphomas with MYC and BCL2 rearrangements2024 · 1 citations
  2. 2Stepwise engineering of human germinal center B cells to model dark zone high-grade B cell lymphoma driven by sequential BCL2 and MYC deregulation2025
  3. 3Clinical outcomes, patterns of relapse and molecular landscape of advanced stage High Grade B-cell Lymphoma2026
  4. 4Targeting DNA interstrand crosslinks repair with synthetic lethality in High-Grade B-Cell Lymphoma2026
  5. 5Evaluation of Immunohistochemical Expression of C-MYC, BCL2, and BCL6 in High Grade B-cell Lymphoma2026